Assessment of the Fungal Infection Incidence Across Canada for High Risk Participants With Hematological Disease (P07501)

Temporal Realistic Assessment of the Fungal Infection Incidence Across Canada for High Risk Subjects With Hematological Disease (TRAFIC)

This will be a retrospective study that includes retrospective chart reviews at major institutions across Canada. The intent of the study is to generate both regional and national incidence data for non-Candida invasive fungal infections (IFI) in high risk participants. The study will include participants receiving stem cell transplant and high dose chemotherapy treatment for leukemia.

Inclusion Criteria:

• To be eligible for study inclusion, the participant must have:
• A hematological malignancy requiring high dose chemotherapy with or without bone marrow transplant

Exclusion Criteria:

• The participant is not eligible for study inclusion if:
• Their IFI is not related to hematological malignancies.